March 4, 2019
Kemin enters into new partnership for enzyme production with Chinese company
Kemin Industries had announced last month a new partnership with CRVAB Bio-technology Co., Ltd. which is based in Chifeng, Inner Mongolia, China.
The investment will give Kemin fermentation and production capabilities, further expanding its global reaching enzyme production. This will allow Kemin to directly control its production of enzymes and provide customers with higher quality solutions and "even greater consistency in enzyme products," the company said.
"With this investment, we will be able to better serve more customers in the global feed enzymes markets and will become basic in enzyme production," said Dr. Chris Nelson, president and CEO of Kemin Industries. "As a company founded on science and innovation to improve lives around the world, we are always searching for ways to create impact and this new partnership allows us to expand into areas like food and textile applications."
Kemin will have expanded resources for innovations in both single and blended enzymes as well as probiotic product pipelines as Kemin works on a new product portfolio to bring enzyme products to market. The investment will give Kemin one of the most efficient fermentation facilities in China and an accelerated ability to bring products to Kemin customers.
"We are very excited to have Kemin as a trusted partner. This will significantly improve our capability and allow us to produce products meeting the highest international quality standards," said Peijun Wu, chairman of CRVAB Bio-technology.
"As the feed and animal production industry continues to evolve, customers are searching more aggressively for innovations that add real value," said GS Ramesh, Kemin's global group president for animal nutrition and health.
"Kemin continues to be the key driver of product and technology innovations globally. This new partnership will further strengthen our capability to quickly scale up new innovations, while maintaining our quality and safety standards for global regulatory requirements."
- Kemin / PRNewswire